ro 22-3581 has been researched along with N1-(5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abell, C; Chaikuad, A; Ciulli, A; Fedorov, O; Felletar, I; Ferguson, FM; Heightman, T; Knapp, S; Muniz, JR; Philpott, M; von Delft, F | 1 |
1 other study(ies) available for ro 22-3581 and N1-(5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
| Article | Year |
|---|---|
Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.
Topics: Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Proteins; Structure-Activity Relationship; Transcription Factors, General; Zinc Fingers | 2013 |